St. Jude Medical is releasing in Europe and Japan its OPTIS Mobile System that combines optical coherence tomography (OCT) and angiography co-registration with fractional flow reserve (FFR) measurement. Offering similar features as the stationary OPTIS Integrated System, the portable device can instead be transported and shared between multiple cath labs within the same hospital.
The system allows for fast internal coronary imaging while seeing the location being analyzed on the angiogram. At the same time, hemodynamic information via the company’s PressureWire FFR technology is provided to the physician to make a more comprehensive assessment of the patient’s condition.
From St. Jude Medical:
The benefits of utilizing OCT and FFR during PCI are supported by a robust portfolio of clinical data. The ILUMIEN I and ILUMIEN II studies have shown that St. Jude Medical’s OCT imaging technology can influence pre- and post-PCI decision making, stent sizing and deployment. The St. Jude Medical sponsored FAME body of evidence demonstrated St. Jude Medical PressureWire FFR measurement technology can improve patient outcomes and reduce costs in patients with stable coronary artery disease.
The multicenter ILUMIEN III: OPTIMIZE PCI clinical trial is currently underway to further develop the body of clinical evidence supporting OCT technology in relation to first generation imaging tools.
Source: St. Jude Medical…